AI/ML for Early Drug Discovery Icon

Cambridge Healthtech Institute’s 2nd Annual

AI/ML for Early Drug Discovery

Improving Speed and Efficiency of Target Discovery, Drug Design and Lead Optimization

12 - 13 November 2025 ALL TIMES CET+1

 

Cambridge Healthtech Institute’s annual conference on Artificial Intelligence (AI)/Machine Learning (ML) for Early Drug Discovery brings together chemists, biologists, data scientists and bioinformaticians to discuss how AI predictions and ML algorithms can enable data-driven decision-making for drug discovery. Case studies presented by experts in academia and industry highlight where AI/ML has been integrated and implemented in drug discovery. Time for informal, open-ended discussions allow for sharing knowledge and insights on where AI/ML works well and where it does not.

 






For more details on the conference, please contact:

Tanuja Koppal, PhD

Senior Conference Director

Cambridge Healthtech Institute

Email: tkoppal@healthtech.com

 

For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431

Email: kskahan@healthtech.com


Register Early and Save
Next-Gen Degraders & Molecular Glues
Protein-Protein Interactions

Learn About Our U.S. Event